Literature DB >> 15718415

Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation.

David A Davis1, Kathleen E Singer, Maria De La Luz Sierra, Masashi Narazaki, Fuquan Yang, Henry M Fales, Robert Yarchoan, Giovanna Tosato.   

Abstract

The chemokine stromal-derived factor-1alpha (SDF-1alpha) is an essential regulator of hematopoiesis, lymphocyte homing, pre-B-cell growth, and angiogenesis. As SDF-1alpha is constitutively expressed in many tissues, chemokine function is mostly regulated by proteolytic degradation. Human serum cleaves the 68-amino acid chemokine, SDF-1alpha, at both termini. The enzyme or enzymes responsible for the removal of the carboxy-terminal lysine from SDF-1alpha, leading to significant reduction in biologic activity, have not been identified. Using a new biochemical assay for measuring the carboxy-terminal cleavage activity, we purified from serum and plasma a peptidase that specifically removes the carboxy-terminal lysine from SDF-1alpha and identified it as carboxypeptidase N (CPN, also known as kininase I, arginine carboxypeptidase, and anaphylotoxin inactivator). We demonstrate that SDF-1alpha in serum and plasma lacks the carboxy terminal lysine, and depletion of CPN from serum and plasma significantly reduces the SDF-1alpha carboxypeptidase activity. Purified CPN effectively and specifically removes the carboxy-terminal lysine from SDF-1alpha and significantly reduces the chemokine's biologic activity as a pre-B-cell growth factor and chemoattractant. Thus, in addition to its role as a regulator of the biologic activity of kinins and anaphylatoxins, CPN is an important regulator of the biologic activity of SDF-1alpha by reducing the chemokine-specific activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718415      PMCID: PMC1895000          DOI: 10.1182/blood-2004-12-4618

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.

Authors:  T Nagasawa; S Hirota; K Tachibana; N Takakura; S Nishikawa; Y Kitamura; N Yoshida; H Kikutani; T Kishimoto
Journal:  Nature       Date:  1996-08-15       Impact factor: 49.962

Review 2.  Basic carboxypeptidases: regulators of peptide hormone activity.

Authors:  R A Skidgel
Journal:  Trends Pharmacol Sci       Date:  1988-08       Impact factor: 14.819

3.  Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins.

Authors:  K Tashiro; H Tada; R Heilker; M Shirozu; T Nakano; T Honjo
Journal:  Science       Date:  1993-07-30       Impact factor: 47.728

4.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.

Authors:  C C Bleul; M Farzan; H Choe; C Parolin; I Clark-Lewis; J Sodroski; T A Springer
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

5.  Differential pharmacology of cloned human and mouse B2 bradykinin receptors.

Authors:  J F Hess; J A Borkowski; T Macneil; G Y Stonesifer; J Fraher; C D Strader; R W Ransom
Journal:  Mol Pharmacol       Date:  1994-01       Impact factor: 4.436

6.  Conversion of MM creatine kinase isoforms in human plasma by carboxypeptidase N.

Authors:  D R Abendschein; H Serota; T H Plummer; K Amiraian; A W Strauss; B E Sobel; A S Jaffe
Journal:  J Lab Clin Med       Date:  1987-12

7.  Molecular cloning and structure of a pre-B-cell growth-stimulating factor.

Authors:  T Nagasawa; H Kikutani; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

8.  The deduced protein sequence of the human carboxypeptidase N high molecular weight subunit reveals the presence of leucine-rich tandem repeats.

Authors:  F Tan; D K Weerasinghe; R A Skidgel; H Tamei; R K Kaul; I B Roninson; J W Schilling; E G Erdös
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

9.  Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene.

Authors:  M Shirozu; T Nakano; J Inazawa; K Tashiro; H Tada; T Shinohara; T Honjo
Journal:  Genomics       Date:  1995-08-10       Impact factor: 5.736

10.  Cloning and pharmacological characterization of bradykinin receptors.

Authors:  J F Hess; J A Borkowski; G Y Stonesifer; T MacNeil; C D Strader; R W Ransom
Journal:  Braz J Med Biol Res       Date:  1994-08       Impact factor: 2.590

View more
  38 in total

Review 1.  Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells.

Authors:  Aysegul Ocal Sahin; Miranda Buitenhuis
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

2.  Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro.

Authors:  Samuel Herberg; Sadanand Fulzele; Nianlan Yang; Xingming Shi; Matthew Hess; Sudharsan Periyasamy-Thandavan; Mark W Hamrick; Carlos M Isales; William D Hill
Journal:  Tissue Eng Part A       Date:  2012-08-21       Impact factor: 3.845

Review 3.  Functional diversity of SDF-1 splicing variants.

Authors:  Miroslaw Janowski
Journal:  Cell Adh Migr       Date:  2009-07-23       Impact factor: 3.405

4.  Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma.

Authors:  Besnik Muqaku; Martin Eisinger; Samuel M Meier; Ammar Tahir; Tobias Pukrop; Sebastian Haferkamp; Astrid Slany; Albrecht Reichle; Christopher Gerner
Journal:  Mol Cell Proteomics       Date:  2016-11-22       Impact factor: 5.911

5.  SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats.

Authors:  Tao Yin; Andrew R Bader; Tim K Hou; Bradley A Maron; Derrick D Kao; Ray Qian; Daniel S Kohane; Diane E Handy; Joseph Loscalzo; Ying-Yi Zhang
Journal:  Biomacromolecules       Date:  2013-10-18       Impact factor: 6.988

Review 6.  Proteolytic regulatory mechanism of chemerin bioactivity.

Authors:  Xiao-Yan Du; Lawrence L K Leung
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2009-12       Impact factor: 3.848

Review 7.  Re-engineered stromal cell-derived factor-1α and the future of translatable angiogenic polypeptide design.

Authors:  William Hiesinger; Andrew B Goldstone; Y Joseph Woo
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

8.  G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells.

Authors:  Hyun Kyung Kim; Maria De La Luz Sierra; Cassin Kimmel Williams; A Virginia Gulino; Giovanna Tosato
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

9.  Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.

Authors:  Wei Zhou; Zheng Jiang; Ningbo Liu; Fenghua Xu; Peie Wen; Yanbing Liu; Weixia Zhong; Xianrang Song; Xiaotian Chang; Xiuli Zhang; Guangsheng Wei; Jinming Yu
Journal:  J Cancer Res Clin Oncol       Date:  2008-08-01       Impact factor: 4.553

Review 10.  Extracellular molecules in hematopoietic stem cell mobilisation.

Authors:  Linda Bendall
Journal:  Int J Hematol       Date:  2016-11-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.